Profile
NSPR ABT BSX-PA BSX SYK MDT
Company Name InspireMD, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $68.62M $239.05B $175.45B $154.29B $143.53B $110.15B
Employees 0.09K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Marvin L. Slosman Robert B. Ford Mr. Michael F. Mahoney Michael F. Mahoney Mr. Kevin A. Lobo Geoffrey Straub Martha
Ratings
NSPR ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
NSPR ABT BSX-PA BSX SYK MDT
Last Close $2.24 $137.4 $122.18 $104.29 $392.23 $85.97
High 52 $3.7 $140.22 $122.18 $106.66 $399.9 $94.5
Low 52 $2.19 $100.07 $122.18 $72.96 $315.94 $76.84
Price vs. 52 Week High -39.46 % -2.01 % 0 % -2.22 % -1.92 % -9.03 %
Price vs. 52 Week Low 2.28 % 37.3 % 0 % 42.94 % 24.15 % 11.88 %
Total Return
NSPR ABT BSX-PA BSX SYK MDT
1 Month Return -11.46 % 4.65 % 0 % -0.2 % 4.14 % 6.56 %
3 Month Return -16.42 % 8.52 % 0 % 1.91 % 6.65 % -2.56 %
6 Month Return -21.95 % 19.2 % 0 % 14.04 % 6.17 % 5.36 %
9 Month Return -17.65 % 21.88 % 0 % 25.53 % 8.55 % -3.89 %
YTD Return -14.83 % 21.47 % 0 % 16.76 % 8.94 % 7.62 %
1 Year Return -10.11 % 31.01 % 0 % 35.27 % 15.19 % 7.4 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NSPR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.66 % - - 0.87 % 3.26 %
Dividend Paid and Capex Coverage Ration (TTM) -16.34 % 1.57 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 76.97 %
Profitability
NSPR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 36.02 % 55.89 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -63.82 % 16.58 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM -64.71 % 30.76 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM -116.67 % 10.5 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 152.74 % 183.58 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 44.24 % 102.35 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -519.77 % 16.97 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -1561.68 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM - 4.38 6.52 6.52 5.86 5.15
Payables Turnover TTM - 4.43 5.74 5.74 - 4.74
Inventory Turnover TTM 1.59 2.81 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 141.64 % 387.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 18.17 % 51.99 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -0.61 5.12 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -0.65 3.81 1.94 1.94 9.37 4.04
Cash Per Share TTM 62.22 % 391.71 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -364.25 % 21.14 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 106.12 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -1561.68 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -2.53 35.91 53.62 53.7 40.12 21.24
Price To Operating Cash Flows Ratio TTM -3.67 26.82 40.35 40.41 33.43 15.65
Price Cash Flow Ratio TTM -3.67 26.82 40.35 40.41 33.43 15.65
Income Statement (TTM)
NSPR ABT BSX-PA BSX SYK MDT
Revenue $0.01B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 21.49% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.03B $10.83B $3.94B $3.94B $5.72B $5.96B
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -0.76 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
NSPR ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.84B $8.84B $12.19B $25.64B
Total Liabilities $0.01B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.04B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0.02B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.05B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
NSPR ABT BSX-PA BSX SYK MDT
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 136.42
ADGM Adagio Medical Holdings, Inc. 1.2201
AEMD Aethlon Medical, Inc. 1.58
AFIB Acutus Medical, Inc. 0.004
AHCO AdaptHealth Corp. 9.24
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 188.3
ALUR Allurion Technologies Inc. 2.53
AMIX Autonomix Medical, Inc. Common Stock 1.2844
ANIK Anika Therapeutics, Inc. 10.93
AORT Artivion, Inc. 30.52
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.97
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.155
AVNS Avanos Medical, Inc. 12.23
AVR Anteris Technologies Global Corp. Common Stock 4.02
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 10.319
Unlock